Similar articles

• Diabetes under control: Understanding oral antidiabetic agents.

  Longo R. Longo R. Am J Nurs. 2010 Feb;110(2):49-52. doi: 10.1097/01.NAJ.0000368053.80352.19. Am J Nurs. 2010. PMID: 20107402 No abstract available.
• Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes.

  Ferrannini E, DeFronzo RA. Ferrannini E, et al. Eur Heart J. 2015 Sep 7;36(34):2288-96. doi: 10.1093/eurheartj/ehv239. Epub 2015 Jun 10. Eur Heart J. 2015. PMID: 26063450 Review.
• Drugs for type 2 diabetes.

  [No authors listed] [No authors listed] Treat Guidel Med Lett. 2008 Jul;6(71):47-54. Treat Guidel Med Lett. 2008. PMID: 18583949 Review. No abstract available.
• Preventing the progressive nature of type 2 diabetes.

  [No authors listed] [No authors listed] Cardiovasc J S Afr. 2002 Jul-Aug;13(4):211-3. Cardiovasc J S Afr. 2002. PMID: 12402899 No abstract available.
• Diabetes Update: New Pharmacotherapy for Type 2 Diabetes.

  Choby B. Choby B. FP Essent. 2017 May;456:27-35. FP Essent. 2017. PMID: 28530382 Review.